Clinithink Appoints Mark Johnston As Chief Executive Officer, Dr. Chris Tackaberry To Transition To Executive Vice President
Mar 13, 2024•over 1 year ago
Company
Clinithink
Description
Clinithink announces the appointment of Mark Johnston as its new Chief Executive Officer (CEO), succeeding Dr. Chris Tackaberry who will transition to the role of Executive Vice President of Population Health and Life Sciences. Mark Johnston's proven track record in scaling healthcare technology companies positions him well to lead Clinithink’s future growth.
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months